Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.47M Sell
24,706
-3,929
-14% -$493K ﹤0.01% 934
2026
Q1
$3.47M Buy
28,635
+725
+3% +$91.6K ﹤0.01% 891
2025
Q4
$3.8M Buy
27,910
+2,498
+10% +$368K ﹤0.01% 866
2025
Q3
$4.05M Buy
25,412
+510
+2% +$86.7K ﹤0.01% 834
2025
Q2
$4.45M Sell
24,902
-544
-2% -$92.4K 0.01% 769
2025
Q1
$4.08M Buy
25,446
+472
+2% +$85.8K 0.01% 788
2024
Q4
$4.35M Buy
24,974
+355
+1% +$69K 0.01% 738
2024
Q3
$5.36M Buy
24,619
+2,441
+11% +$542K 0.01% 616
2024
Q2
$4.96M Buy
+22,178
New +$5.14M 0.01% 581
2022
Q2
Sell
-15,189
Closed -$2.72M 1384
2022
Q1
$2.72M Buy
15,189
+1,489
+11% +$272K 0.01% 634
2021
Q4
$2.81M Buy
13,700
+1,179
+9% +$224K 0.01% 626
2021
Q3
$2.28M Buy
12,521
+1,076
+9% +$203K 0.01% 645
2021
Q2
$2M Buy
+11,445
New +$1.97M ﹤0.01% 670

Other funds holding CDW

VanEck Associates's CDW Position: Q2 2026 in Review

VanEck Associates reduced its CDW (CDW) stake by 14% in Q2 2026, selling an estimated $493K and leaving 24,706 shares worth $3.47M. The position accounts for ﹤0.01% of the portfolio, ranked #934.

VanEck Associates first reported a position in CDW in Q2 2021 and has held it in 13 quarters since. The position peaked at $5.36M in Q3 2024. 757 funds tracked by Wall St. Rank hold CDW as of Q2 2026.

  • VanEck Associates held 24,706 shares of CDW worth $3.47M as of Q2 2026.
  • VanEck Associates sold 3,929 CDW shares in Q2 2026, an estimated $493K.
  • CDW made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #934 holding.
  • VanEck Associates first reported a position in CDW in Q2 2021 and has held it in 13 quarters since.
  • VanEck Associates's CDW position peaked at $5.36M in Q3 2024.
  • 757 funds tracked by Wall St. Rank held CDW as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.